Literature DB >> 6127787

Relationship between ranitidine plasma levels and reduction of postprandial intragastric acidity in healthy man.

A Berstad, K Frislid, A Rydning.   

Abstract

Intragastric acidity was measured for 20 min before and 6 h 40 min after a steak meal by aspiration of small aliquots of the gastric content every 10 min in 11 healty volunteers. Administration of ranitidine hydrochloride (100 mg) at the beginning of the meal reduced postprandial acidity markedly throughout the test, but there was no correlation between the percentage reduction of acidity and the concentration of ranitidine in plasma. The effect of the drug lasted much longer than would be expected from the plasma values. The results suggest that ranitidine is cleared more rapidly from the blood than from the H2-receptors of the parietal cells, and the reduction of postprandial acidity by ranitidine cannot be deduced from the plasma values of the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127787     DOI: 10.3109/00365528209181053

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.

Authors:  J H Lin
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.

Authors:  D B Jones; C W Howden; D W Burget; G D Kerr; R H Hunt
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

3.  High dose of antacid reduces bioavailability of ranitidine.

Authors:  K Frislid; A Berstad
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

4.  Clinical assessment of antisecretory drugs in man.

Authors:  E J Boyd; K G Wormsley
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

Review 5.  Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Authors:  J G Hatlebakk; A Berstad
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of ranitidine.

Authors:  C J Roberts
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man.

Authors:  J L Smith; M A Gamal; A N Chremos; D Y Graham
Journal:  Dig Dis Sci       Date:  1985-04       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.